US Stock MarketDetailed Quotes

ZURA Zura Bio

Watchlist
  • 3.000
  • -0.010-0.33%
Close Nov 27 16:00 ET
  • 3.000
  • 0.0000.00%
Post 16:00 ET
195.88MMarket Cap-4594P/E (TTM)

Zura Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-119.88%-5.65M
-27.91%-6.62M
-52.96%-4.98M
-1,152.41%-15.05M
-4.05M
-2.57M
-5.17M
-3.26M
-9.46%-1.2M
-1.1M
Net income from continuing operations
-150.33%-20.7M
69.64%-10.33M
20.91%-7.75M
-121.57%-60.56M
---8.47M
---8.27M
---34.03M
---9.8M
-499.10%-27.33M
--6.85M
Operating gains losses
3,343.70%3.86M
44.80%766K
447.02%583K
-3,321.74%-741K
---983K
---119K
--529K
---168K
100.27%23K
---8.48M
Depreciation and amortization
--3K
----
----
----
----
--0
----
----
----
----
Other non cash items
----
----
----
41.59%31.48M
--0
--0
--27.38M
--4.1M
2,776.33%22.23M
--772.97K
Change In working capital
-21.63%2.54M
101.38%19K
-193.80%-227K
44.48%5.12M
--3.01M
--3.24M
---1.38M
--242K
1,602.96%3.54M
---235.6K
-Change in receivables
----
----
----
----
----
----
----
----
----
--2.87K
-Change in prepaid assets
236.95%278K
-247.22%-375K
278.40%380K
-296.17%-828K
---304K
---203K
---108K
---213K
50.58%-209K
---422.89K
-Change in payables and accrued expense
-34.32%2.26M
131.07%394K
-233.41%-607K
58.51%5.94M
--3.31M
--3.44M
---1.27M
--455K
1,933.40%3.75M
--184.42K
Cash from discontinued investing activities
Operating cash flow
-119.88%-5.65M
-27.91%-6.62M
-52.96%-4.98M
-1,152.41%-15.05M
---4.05M
---2.57M
---5.17M
---3.26M
-9.46%-1.2M
---1.1M
Investing cash flow
Cash flow from continuing investing activities
99.42%-13K
99.83%-10K
-5.01M
33.33%-8M
0
-2.25M
-5.75M
0
91.39%-12M
-139.38M
Net PPE purchase and sale
---13K
---10K
---7K
----
----
--0
--0
--0
----
----
Net intangibles purchase and sale
--0
--0
---5M
33.33%-8M
--0
---2.25M
---5.75M
--0
---12M
----
Net other investing changes
----
----
----
----
----
----
----
----
----
---139.38M
Cash from discontinued investing activities
Investing cash flow
99.42%-13K
99.83%-10K
---5.01M
33.33%-8M
--0
---2.25M
---5.75M
--0
91.39%-12M
---139.38M
Financing cash flow
Cash flow from continuing financing activities
232.07%5.44M
31.96%105.25M
0
721.27%121.29M
0
-4.12M
79.76M
45.65M
-89.54%14.77M
141.21M
Net issuance payments of debt
--0
--0
--0
-231.58%-10M
--0
--0
--0
---10M
6,574.64%7.6M
---117.38K
Net common stock issuance
234.26%5.53M
-13.51%55.22M
--0
--116.41M
--0
---4.12M
--63.85M
--56.68M
--0
--138M
Net preferred stock issuance
----
----
----
--0
----
----
----
----
--10M
----
Proceeds from stock option exercised by employees
--0
----
----
--16.07M
--0
--0
----
----
--0
----
Net other financing activities
----
----
----
58.18%-1.18M
--0
--0
---154K
---1.03M
-185.15%-2.83M
--3.32M
Cash from discontinued financing activities
Financing cash flow
232.07%5.44M
31.96%105.25M
--0
721.27%121.29M
--0
---4.12M
--79.76M
--45.65M
-89.54%14.77M
--141.21M
Net cash flow
Beginning cash position
67.06%188.44M
104.30%89.82M
6,269.24%99.81M
--1.57M
--103.86M
--112.8M
--43.96M
--1.57M
--0
--0
Current changes in cash
97.52%-222K
43.27%98.63M
-123.56%-9.99M
6,169.24%98.24M
---4.05M
---8.94M
--68.84M
--42.4M
114.89%1.57M
--729.22K
End cash Position
81.23%188.22M
67.06%188.44M
104.30%89.82M
6,269.24%99.81M
--99.81M
--103.86M
--112.8M
--43.96M
114.89%1.57M
--729.22K
Free cash flow
-17.53%-5.67M
39.33%-6.63M
-206.69%-9.99M
-74.63%-23.05M
---4.05M
---4.82M
---10.92M
---3.26M
-1,102.21%-13.2M
---1.1M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -119.88%-5.65M-27.91%-6.62M-52.96%-4.98M-1,152.41%-15.05M-4.05M-2.57M-5.17M-3.26M-9.46%-1.2M-1.1M
Net income from continuing operations -150.33%-20.7M69.64%-10.33M20.91%-7.75M-121.57%-60.56M---8.47M---8.27M---34.03M---9.8M-499.10%-27.33M--6.85M
Operating gains losses 3,343.70%3.86M44.80%766K447.02%583K-3,321.74%-741K---983K---119K--529K---168K100.27%23K---8.48M
Depreciation and amortization --3K------------------0----------------
Other non cash items ------------41.59%31.48M--0--0--27.38M--4.1M2,776.33%22.23M--772.97K
Change In working capital -21.63%2.54M101.38%19K-193.80%-227K44.48%5.12M--3.01M--3.24M---1.38M--242K1,602.96%3.54M---235.6K
-Change in receivables --------------------------------------2.87K
-Change in prepaid assets 236.95%278K-247.22%-375K278.40%380K-296.17%-828K---304K---203K---108K---213K50.58%-209K---422.89K
-Change in payables and accrued expense -34.32%2.26M131.07%394K-233.41%-607K58.51%5.94M--3.31M--3.44M---1.27M--455K1,933.40%3.75M--184.42K
Cash from discontinued investing activities
Operating cash flow -119.88%-5.65M-27.91%-6.62M-52.96%-4.98M-1,152.41%-15.05M---4.05M---2.57M---5.17M---3.26M-9.46%-1.2M---1.1M
Investing cash flow
Cash flow from continuing investing activities 99.42%-13K99.83%-10K-5.01M33.33%-8M0-2.25M-5.75M091.39%-12M-139.38M
Net PPE purchase and sale ---13K---10K---7K----------0--0--0--------
Net intangibles purchase and sale --0--0---5M33.33%-8M--0---2.25M---5.75M--0---12M----
Net other investing changes ---------------------------------------139.38M
Cash from discontinued investing activities
Investing cash flow 99.42%-13K99.83%-10K---5.01M33.33%-8M--0---2.25M---5.75M--091.39%-12M---139.38M
Financing cash flow
Cash flow from continuing financing activities 232.07%5.44M31.96%105.25M0721.27%121.29M0-4.12M79.76M45.65M-89.54%14.77M141.21M
Net issuance payments of debt --0--0--0-231.58%-10M--0--0--0---10M6,574.64%7.6M---117.38K
Net common stock issuance 234.26%5.53M-13.51%55.22M--0--116.41M--0---4.12M--63.85M--56.68M--0--138M
Net preferred stock issuance --------------0------------------10M----
Proceeds from stock option exercised by employees --0----------16.07M--0--0----------0----
Net other financing activities ------------58.18%-1.18M--0--0---154K---1.03M-185.15%-2.83M--3.32M
Cash from discontinued financing activities
Financing cash flow 232.07%5.44M31.96%105.25M--0721.27%121.29M--0---4.12M--79.76M--45.65M-89.54%14.77M--141.21M
Net cash flow
Beginning cash position 67.06%188.44M104.30%89.82M6,269.24%99.81M--1.57M--103.86M--112.8M--43.96M--1.57M--0--0
Current changes in cash 97.52%-222K43.27%98.63M-123.56%-9.99M6,169.24%98.24M---4.05M---8.94M--68.84M--42.4M114.89%1.57M--729.22K
End cash Position 81.23%188.22M67.06%188.44M104.30%89.82M6,269.24%99.81M--99.81M--103.86M--112.8M--43.96M114.89%1.57M--729.22K
Free cash flow -17.53%-5.67M39.33%-6.63M-206.69%-9.99M-74.63%-23.05M---4.05M---4.82M---10.92M---3.26M-1,102.21%-13.2M---1.1M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data